AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024
Psychedelics Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index MindMed's lead drug candidate is an LSD-like therapeutic used to treat anxiety Rowan DunneDecember 20, 2024
Psychedelics Can psychedelics help with chronic pain? Research shows that substances like Psychedelics like LSD, DMT and magic mushrooms can be used in medicine Adeline EeMay 24, 2024
Health & Wellness Microdosing LSD shows potential antidepressant effects in landmark study Results of the study were published in the journal Neuropsychopharmacology Zartasha MushtaqJanuary 20, 2024
Health & Wellness Compass Pathways, Hackensack Meridian Health collaborate on psilocybin treatment research Partnership signals a milestone agreement for innovative treatment solutions Zartasha MushtaqJanuary 19, 2024
Psychedelics Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010 Rowan DunneAugust 10, 2023
News LSD microdosing shows promise as treatment for major depression: MindBio study MindBio Therapeutics (CSE:MBIO) says microdoses of LSD could help improve mood and treat mental health conditions such as depression. The Melbourne-based pharmaceutical company announced... Natalia Buendia CalvilloMay 10, 2023
Psychedelics Woke Pharma and Swinburne U partner for Australia’s biggest psilocybin trial The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression Rowan DunneFebruary 1, 2023
Health & Wellness Sharecare offers educational content for mindfulness and mental well being Sharecare is a digital health company that helps people to collect and manage their health data. Joseph MortonOctober 11, 2022
Canada VIVO Cannabis study finds medical cannabis effective in treating anxiety and depression The study was the largest of its kind to date, examining the impact of medical cannabis on anxiety and depression in 7,362 Canadian patients Ryan GarnerJune 7, 2022